Our services:
Designed for how you work
Drawing on extensive pricing experience, we guide you with strategies, processes and tools that fit your organisation and support confident decision making.
Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.
We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.
Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.
Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.
We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.
Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.
Client testimonials
Pricing and
Payer Launch
Strategy
- Payer landscape assessment
- Early health economic analysis
- Payer evidence gap analysis
- HEOR strategy & study design
- Go-to-market model
- Indication & launch sequencing
- Launch pricing strategy
- Asset value assessment
HTA/
Reimbursement
Submissions
- Early HTA/payer advice
- Payer advisory boards
- Health economic model
- Global value dossier
- Stakeholder engagement
- Submission support
- Formulary access tools
- Price requests & certificates
Life Cycle
Management
Strategy
- Loss of exclusivity strategy
- Pricing maturity assessment
- Net price optimisation
- Contracting strategy
- Real-world evidence application
- Local access optimisation
- Gross-to-Net strategy
- Price governance development
Pricing and
Payer Launch
Strategy
- Payer landscape assessment
- Early health economic analysis
- Payer evidence gap analysis
- HEOR strategy & study design
- Go-to-market model
- Indication & launch sequencing
- Launch pricing strategy
- Asset value assessment
HTA/
Reimbursement
Submissions
- Early HTA/payer advice
- Payer advisory boards
- Health economic model
- Global value dossier
- Stakeholder engagement
- Submission support
- Formulary access tools
- Price requests & certificates
Life Cycle
Management
Strategy
- Loss of exclusivity strategy
- Pricing maturity assessment
- Net price optimisation
- Contracting strategy
- Real-world evidence application
- Local access optimisation
- Gross-to-Net strategy
- Price governance development
End-To-End Market Access and Pricing Consulting
Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational.
How We Support the Full Product Lifecycle
This graph illustrates the strategic support Pricia provides across the entire product lifecycle.
- In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
- As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
- In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.
The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.
End-To-End Market Access and Pricing Consulting
Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational.
How We Support the Full Product Lifecycle
This graph illustrates the strategic support Pricia provides across the entire product lifecycle.
- In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
- As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
- In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.
The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.
Real-world evidence can bring value to mature products
"The full value of a healthcare innovation is not yet documented when a product is approved and hits the market. Today, we generate more and more health data. Real-world evidence offers an opportunity to optimise local market access and mitigate loss-of-exclusivity price decreases."
Martin Nottmeier
Market Access Lead
Real-world evidence can bring value to mature products
"The full value of a healthcare innovation is not yet documented when a product is approved and hits the market. Today, we generate more and more health data. Real-world evidence offers an opportunity to optimise local market access and mitigate loss-of-exclusivity price decreases."
Martin Nottmeier
Market Access Lead
Ready to talk?
We're ready to listen.
Whether you’re developing your product, planning a first launch, re-evaluating your market access strategy or looking to optimise pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.
Reach out to discuss your needs and learn how we tailor solutions that deliver results.
Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.
Ready to talk?
We're ready to listen.
Whether you’re developing your product, planning a first launch, re-evaluating your market access strategy or looking to optimise pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.
Reach out to discuss your needs and learn how we tailor solutions that deliver results.
Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.
Our services: Designed for how you work
Drawing on extensive pricing experience, we
guide you with strategies, processes and tools
that fit your organisation and support confident decision making.
Working with Pricia means gaining a partner who is personally invested in your success, not just delivering a service.
At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver.
We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality.
Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.
Client testimonials
Pricing and
Payer Launch
Strategy
- Payer landscape assessment
- Early health economic analysis
- Payer evidence gap analysis
- HEOR strategy & study design
- Go-to-market model
- Indication & launch sequencing
- Launch pricing strategy
- Asset value assessment
HTA/
Reimbursement
Submissions
- Early HTA/payer advice
- Payer advisory boards
- Health economic model
- Global value dossier
- Stakeholder engagement
- Submission support
- Formulary access tools
- Price requests & certificates
Life Cycle
Management
Strategy
- Loss of exclusivity strategy
- Pricing maturity assessment
- Net price optimisation
- Contracting strategy
- Real-world evidence application
- Local access optimisation
- Gross-to-Net strategy
- Price governance development
End-To-End Market Access and Pricing Consulting
Pricing is a continuous balance between product cost and payer outcomes
– It starts strategic, then becomes dynamic and operational.
How We Support the Full Product Lifecycle
This graph illustrates the strategic support Pricia provides across the entire product lifecycle.
- In the early life science phases, we guide clients through Pricing and Payer Launch Strategy, including payer landscape assessment, early health economic analysis, evidence gap identification and go-to-market planning.
- As products approach launch and market introduction, we support HTA and Reimbursement Submissions, helping clients prepare global value dossiers, engage with stakeholders and navigate the submission process.
- In the growth, maturity and decline stages, we provide Life Cycle Management Strategy, including loss of exclusivity planning, contracting and net price optimisation, local access support and the strategic use of real-world evidence.
The result is end-to-end alignment of pricing, market access and payer engagement, ensuring clients are prepared not only for launch, but for long-term market success.
Real-world evidence can bring value to mature products
"The full value of a healthcare innovation is not yet documented when a product is approved and hits the market. Today, we generate more and more health data. Real-world evidence offers an opportunity to optimise local market access and mitigate loss-of-exclusivity price decreases."
Martin Nottmeier
Market Access Lead
Ready to talk?
We're ready to listen.
Whether you’re developing your product, planning a first launch, re-evaluating your market access strategy or looking to optimise pricing operations, our team is ready to help. At Pricia, every project starts with a conversation — not a pitch.
Reach out to discuss your needs and learn how we tailor solutions that deliver results.
Use our contact form to connect directly with the Pricia team. You can expect a response within one business day.